UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000006155
Receipt No. R000007279
Official scientific title of the study Evaluation of Aboral Pouch Reconstruction After Total Gastrectomy in Patients with Gastric Cancer : A Prospective Randomized Controlled Trial
Date of disclosure of the study information 2011/08/16
Last modified on 2017/02/17 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of Aboral Pouch Reconstruction After Total Gastrectomy in Patients with Gastric Cancer : A Prospective Randomized Controlled Trial
Title of the study (Brief title) CCOG1101
Region
Japan

Condition
Condition Gastric cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aboral pouch reconstruction is compared with simple Roux-en-Y reconstruction in a randomized controlled trial to identify the optimal reconstruction procedure after total gastrectomy for patients with gastric cancer.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Phase III

Assessment
Primary outcomes Assessment of Quality of Life after Total Gastrectomy
Key secondary outcomes Body weight
Nutritional status
Operation time
Blood loss during the operation
Surgical complications


Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 A: Roux-en-Y reconstruction
Interventions/Control_2 B: Aboral pouch reconstruction
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1st inclusion criteria (before surgery)
1) Histologically proven primary gastric adenocarcinoma
2) Candidate for R0 surgery by total gastrectomy for patients with gastric cancer
3) Length of esophageal invasion less than or equal to 3cm with no need for thoracotomy for resection
4) Borrmann type 4 and large (8cm or more in diameter) type 3 excluded
5) Not cancer of the remnant stomach
6) No history of upper abdominal surgery and no history of intestinal resection
7) No prior treatment of chemotherapy or radiation therapy against any other malignancies
8) Age 20 to 80 years old
9) PS (ECOG) of 0 or 1
10) Adequate organ functions for gastrectomy
11) Written informed consent from the patient

2nd inclusion criteria (during surgery)
1) cT1 - cT4a
2) cN0-2 H0 P0 M0
3) R0 resection possible, or R1 resection due only to CY1
4) No need for thoracotomy
Key exclusion criteria 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ
2) Body mass index more than 28
3) Uncontrollable hypertension or uncontrollable diabetes mellitus
4) Continuous systemic steroid therapy
5) Otherwise considered inadequate for inclusion in this trial by the physician
Target sample size 90

Research contact person
Name of lead principal investigator Yasuhiro Kodera
Organization Nagoya University Graduate School of Medicine
Division name Department of Surgery II
Address 65 Tsurumai-cho, Showa-ku, Nagoya, Japan
TEL 052-744-2250
Email miyuki.a@med.nagoya-u.ac.jp

Public contact
Name of contact person Yuichi Ito
Organization Aichi Cancer Center Hospital
Division name Department of Gastroenterological Surgery
Address 1-1 Kanokoden, Chikuda-ku, Nagoya, Japan
TEL 052-762-6111
Homepage URL
Email yuichi@aichi-cc.jp

Sponsor
Institute Chubu Clinical Oncology Group (CCOG)
Institute
Department

Funding Source
Organization Chubu Clinical Oncology Group (CCOG)
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 08 Month 16 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2011 Year 06 Month 22 Day
Anticipated trial start date
2011 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 08 Month 12 Day
Last modified on
2017 Year 02 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007279